Matthew L. Anderson

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Table 1 from Geospatial Analysis of Accredited Lung Cancer Screening Facilities in Florida Reveals Suboptimal Alignment with High-Risk Populations

  2026-06-18

• Table 3 from Geospatial Analysis of Accredited Lung Cancer Screening Facilities in Florida Reveals Suboptimal Alignment with High-Risk Populations

  2026-06-18

• Table 2 from Geospatial Analysis of Accredited Lung Cancer Screening Facilities in Florida Reveals Suboptimal Alignment with High-Risk Populations

  2026-06-18

• Data from Geospatial Analysis of Accredited Lung Cancer Screening Facilities in Florida Reveals Suboptimal Alignment with High-Risk Populations

  2026-06-18

• Geospatial Analysis of Accredited Lung Cancer Screening Facilities in Florida Reveals Suboptimal Alignment with High-Risk Populations

  Cancer Research Communications · 2026-01-07

• Abstract B012: Results From the Phase 1 Dose Escalation and Dose Expansion Study of Azenosertib, a WEE1 Inhibitor, in Patients With Advanced Solid Tumors

  Molecular Cancer Therapeutics · 2025-10-22

• Abstract B025: Follow up after a positive HPV test result: Results from the PRESTIS study

  Cancer Epidemiology Biomarkers & Prevention · 2025-09-18

• Handheld Point-of-Care Ultrasonography for Gynecology

  Obstetrics and Gynecology · 2025-07-24 · 1 citations

• Uterine Transposition for Fertility Preservation and Ovarian Conservation in Patients Undergoing Pelvic Radiotherapy

  Obstetrics and Gynecology · 2025-07-03 · 4 citations

• Author response: Assessment of the histone mark-based epigenomic landscape in human myometrium at term pregnancy

  2025-06-10

• Self-Collection for Cervical Cancer Screening in a Safety-Net Setting

  JAMA Internal Medicine · 2025-06-06 · 17 citations

• Assessment of the histone mark-based epigenomic landscape in human myometrium at term pregnancy

  eLife · 2025-05-15 · 1 citations

• PARP Inhibitors in Ovarian Cancer: Resistance Mechanisms, Clinical Evidence, and Evolving Strategies

  Biomedicines · 2025-05-06 · 14 citations

• Author response: Assessment of the Histone Mark-based Epigenomic Landscape in Human Myometrium at Term Pregnancy

  2025-04-24

• Assessment of the Histone Mark-based Epigenomic Landscape in Human Myometrium at Term PregnancyPreprint

  eLife · 2025-04-24

• Abstract 5685: Targeting the NR2F6-NACC1-NOTCH3 axis: a promising therapeutic strategy to combat tumor progression and resistance in endometrial cancer

  Cancer Research · 2025-04-21

• Evaluating the Role of Hyperthermic Intraperitoneal Chemotherapy in Cytoreductive Surgery for Advanced-Stage Ovarian Cancer

  Annals of Surgical Oncology · 2025-04-06 · 2 citations

• Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis

  Gynecologic Oncology · 2025-02-18 · 2 citations

• Overexpression of high affinity Type I adenosine receptors promotes the growth of uterine leiomyomas

  Molecular Human Reproduction · 2025-01-01

• Phase I Study of Niraparib with Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix (NIVIX)Preprint

  SSRN Electronic Journal · 2025-01-01